Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02904265 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome
A Phase 2 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT02904265: Clinical Trial Phase 2 study, sponsored by Mayo Clinic.
NCT02904265 is a Phase 2 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02904265, a Phase 2 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam in the treatment of continuous spike wave in sleep (CSWS) and Landau-Kleffner syndrome (LKS).
Primary Outcome
Expect improved side effect profile of acetazolamide compared to diazepam at short-term follow up
Interventions
- DRUG Acetazolamide
- DRUG Diazepam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-07-26 |
| Phase | Phase 2 |
Why NCT02904265 stopped before completion
NCT02904265 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Acetazolamide is the first listed.
NCT02904265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02904265 about?
NCT02904265 is a clinical study titled "Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome". The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam in the treatment of continuous spike wave in sleep (CSWS) and Landau-Kleffner syndrome (LKS).
What is the current status of trial NCT02904265?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2016-09. Estimated completion is 2019-07-26.
What interventions are being tested in trial NCT02904265?
The interventions under investigation include: Acetazolamide (DRUG), Diazepam (DRUG).
Who is sponsoring clinical trial NCT02904265?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02904265's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia